DANIEL PASSERI

Insider Reports History

Location
Boston, MA
Signature
/s/ Daniel Passeri by Colin Sandercock, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by DANIEL PASSERI:

Company Role Class Num Shares Value Price $ Report Date Ownership
Cue Biopharma, Inc. CHIEF EXECUTIVE OFFICER, Director Common Stock 164,578 $169,515 $1.03 16 Dec 2024 Direct
Cue Biopharma, Inc. CHIEF EXECUTIVE OFFICER, Director Stock Option (right to buy) 450,000 21 Mar 2025 Direct

Insider Reports Filed by DANIEL PASSERI

Symbol Company Period Transactions Value $ Form Type Role Filing Time
CUE Cue Biopharma, Inc. 21 Mar 2025 1 $0 4 CHIEF EXECUTIVE OFFICER, Director 25 Mar 2025, 16:00
CUE Cue Biopharma, Inc. 16 Dec 2024 1 +$30,900 4 CHIEF EXECUTIVE OFFICER, Director 18 Dec 2024, 16:00
CUE Cue Biopharma, Inc. 06 Mar 2024 1 $0 4 CHIEF EXECUTIVE OFFICER, Director 08 Mar 2024, 16:00
CUE Cue Biopharma, Inc. 14 Aug 2023 1 +$8,580 4 CHIEF EXECUTIVE OFFICER, Director 16 Aug 2023, 16:07
CUE Cue Biopharma, Inc. 21 Jul 2023 1 $0 4 CHIEF EXECUTIVE OFFICER, Director 25 Jul 2023, 12:28
CUE Cue Biopharma, Inc. 16 Feb 2023 1 $0 4 CHIEF EXECUTIVE OFFICER, Director 21 Feb 2023, 15:59
CUE Cue Biopharma, Inc. 31 Mar 2022 4 -$156,755 4 CHIEF EXECUTIVE OFFICER, Director 04 Apr 2022, 17:29
CUE Cue Biopharma, Inc. 25 Mar 2022 1 $0 4 CHIEF EXECUTIVE OFFICER, Director 29 Mar 2022, 16:08
CUE Cue Biopharma, Inc. 30 Sep 2021 3 -$461,534 4 CHIEF EXECUTIVE OFFICER, Director 08 Oct 2021, 16:00
CUE Cue Biopharma, Inc. 24 Sep 2021 1 +$50,051 4 CHIEF EXECUTIVE OFFICER, Director 27 Sep 2021, 16:30